These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9421463)

  • 1. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).
    Gutierrez-Steil C; Wrone-Smith T; Sun X; Krueger JG; Coven T; Nickoloff BJ
    J Clin Invest; 1998 Jan; 101(1):33-9. PubMed ID: 9421463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes.
    Leverkus M; Yaar M; Gilchrest BA
    Exp Cell Res; 1997 May; 232(2):255-62. PubMed ID: 9168800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
    Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
    J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.
    Buechner SA; Wernli M; Harr T; Hahn S; Itin P; Erb P
    J Clin Invest; 1997 Dec; 100(11):2691-6. PubMed ID: 9389732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of apoptosis stimulus factor and its ligand in the induction of apoptosis in some ultraviolet induced diseases.
    Shaker O; Youssef R
    Dermatol Online J; 2006 Mar; 12(3):4. PubMed ID: 16638418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
    Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
    J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis.
    Ouhtit A; Gorny A; Muller HK; Hill LL; Owen-Schaub L; Ananthaswamy HN
    Am J Pathol; 2000 Dec; 157(6):1975-81. PubMed ID: 11106570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
    Caricchio R; Reap EA; Cohen PL
    J Immunol; 1998 Jul; 161(1):241-51. PubMed ID: 9647230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
    Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
    Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.
    Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G
    Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
    Filipowicz E; Adegboyega P; Sanchez RL; Gatalica Z
    Cancer; 2002 Feb; 94(3):814-9. PubMed ID: 11857317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
    Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
    Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD95L mediates tumor counterattack in vitro but induces neutrophil-independent tumor rejection in vivo.
    Igney FH; Behrens CK; Krammer PH
    Int J Cancer; 2005 Jan; 113(1):78-87. PubMed ID: 15386427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes.
    Qin JZ; Chaturvedi V; Denning MF; Bacon P; Panella J; Choubey D; Nickoloff BJ
    Oncogene; 2002 May; 21(19):2991-3002. PubMed ID: 12082529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.
    Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ
    Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense.
    Berthou C; Michel L; Soulié A; Jean-Louis F; Flageul B; Dubertret L; Sigaux F; Zhang Y; Sasportes M
    J Immunol; 1997 Dec; 159(11):5293-300. PubMed ID: 9548468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet B irradiation induces apoptosis of keratinocytes by direct activation of Fas antigen.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    J Investig Dermatol Symp Proc; 2001 Nov; 6(1):64-8. PubMed ID: 11764289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.